Skip navigation
Agenda

Strategies and Tools to Mitigate Risk and Drive Proactive Monitoring Practices

February 27-28, 2018
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

DAY ONETUESDAY, FEBRUARY 27, 2018

P R E - C O N F E R E N C E W O R K S H O P

7:30

Workshop Registration and Continental Breakfast

8:30

Workshop Leaders’ Welcome and Opening Remarks

Deploying Data Analytics and Other New Technologies to Identify Risk and Drive Effective Compliance

Workshop Leaders:

John Hong
Senior Corporate Counsel, Head of U.S. Compliance Monitoring
Pfizer Inc

Ben Brackbill
Sr. Manager, Head of the Compliance Analytics and Reporting Center of Excellence
Pfizer Inc

Josh Raysman
Leader, Pfizer Analytics Lab
Pfizer Inc

Workshop Outline:

I. An Introduction to How Data Can Be Used to Drive Effective Compliance

II. Approaches for Developing a Compliance Dashboard that Tells a Story — Using Real-Life Examples to Show How an Idea Becomes a Fully Developed, Actionable Piece of Work Product

III. An Examination of Other Innovative Techniques, and the Role They May Have in the Continued Evolution of Our Efforts to Identify and Monitor Risk

12:00

Close of Workshop

There will be a 30-minute networking and refreshment break at 10:00 a.m.

M A I N C O N F E R E N C E

12:00

Main Conference Registration

1:15

Chairman’s Welcome and Opening Remarks

Zachary Coseglia
Assistant General Counsel, Head of Global Compliance Monitoring and Analytics
Pfizer Inc

1:30

KEYNOTE PANEL SESSION OIG and DOJ Enforcement Panel — Recent Trends and Areas of Enforcement

MODERATOR:

Joseph Mack
Senior Compliance Counsel, U.S. Office of Compliance,
Bayer U.S.

PANELISTS:

Bernard Cooney
Assistant United States Attorney
District of New Jersey
U.S. Department of Justice

Eric Rubenstein
Special Agent, U.S. Department of Health and Human Services
Office of Inspector General

Kenneth Abell
Chief Civil Health Care Fraud, Eastern District of New York
U.S. Department of Justice

2:30

LIVE POLLING SESSION Best Practices for Leading a Compliance Monitoring Team

Nancy Mark
Director, Monitoring and Compliance
J&J Medical Devices; Health Care Compliance & Privacy
Johnson & Johnson

Amy Pawloski
Global Lead, Compliance Monitoring Strategy
Bristol-Myers Squibb

3:15

Networking and Refreshment Break

3:45

Mitigate Risk in Patient Engagement and Support Programs through
Proactive Monitoring

Erin E. Atkins
Associate
Arent Fox LLP

Amy Wilson
U.S. Compliance Monitoring and Risk Management Lead
Shire

4:30

Adopting Stronger Compliance and Audit Practices to Mitigate Anti-Bribery and Anti-Corruption Risk with Third-Party Vendors

MODERATOR:

Marcus Green
Head of Independent Business Monitoring, Americas
GSK

PANELISTS:

Christine Zettlemoyer, J.D.
Head of Compliance, Americas and Global Support
CSL Behring

Ashley McQuaide
Director, Internal Audit
Olympus Corporation of the Americas

Lauren M. Hickson
Assosciate Director, Compliance Monitoring and Analytics
Allergan

5:15

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWOWEDNESDAY, FEBRUARY 28, 2018

7:30

Continental Breakfast

8:00

Chairperson’s Review of Day One

Zachary Coseglia
Assistant General Counsel, Head of Global Compliance Monitoring and Analytics
Pfizer Inc

8:15

Analyze Three Implementation Journeys of Compliance Monitoring Programs

MODERATOR:

Shawn Reardon
Principal
Independent Commercial Compliance

PANELISTS:

Stuart Levinsky
Health Care Compliance Monitoring, Medical Devices Group
Johnson & Johnson

Eren A. Efe
Senior Manager, Compliance Auditing & Monitoring
Becton Dickinson

Amy Pawloski
Global Lead, Compliance Monitoring Strategy
Bristol-Myers Squibb

Kristin Campisi
Lead, Compliance Monitoring Operations
Bristol-Myers Squibb

9:15

Design Effective and Cost Conscious Field Force Monitoring Practices

Michael Driscoll
Director Oversight and Monitoring/Risk Assessment, Health Care Compliance
Johnson & Johnson

Stacey Aiken
Sr. Manager, Monitoring Analytics
Johnson & Johnson

10:00

Networking and Refreshment Break

10:30

Right-Size your Global Ethics and Compliance Monitoring Program

Zachary Coseglia
Assistant General Counsel, Head of Global Compliance Monitoring and Analytics
Pfizer Inc

11:15

Commercial Observations from a Compliance Monitor

Dan Koerner
Director
Potomac Partners

12:00

Networking Luncheon

1:15

Overcome Resource Constraints — Build a Strategic Approach to Risk Identification, Monitoring and Auditing

Carrie Ann Ashcom
Director, Compliance Monitoring
Zimmer Biomet

2:00

PANEL SESSION Discuss Best Practices for Proactive Monitoring of Ride-Alongs, Speaker Programs and Third-Party Donations and Grants

MODERATOR:

Zachary Coseglia
Assistant General Counsel, Head of Global Compliance Monitoring and Analytics
Pfizer Inc

PANELISTS:

Kelly Pitt
Director, Legal & Compliance
Sobi, Inc.

Shelley L. Hays-Fisher
Senior Manager, Legal and Compliance Department
Jazz Pharmaceuticals Inc.

Amy Wilson
U.S. Compliance Monitoring and Risk Management Lead
Shire

Ann-Marie Tejcek
Senior Director, Ethics and Compliance, Eli Lilly and Company
USA and Canada

3:00

Close of Conference

Agenda

Want more agenda details? Download the brochure.
Want more agenda details? Download the brochure.

DAY ONETUESDAY, FEBRUARY 27, 2018

P R E - C O N F E R E N C E W O R K S H O P

7:30

Workshop Registration and Continental Breakfast

8:30

Workshop Leaders’ Welcome and Opening Remarks

Deploying Data Analytics and Other New Technologies to Identify Risk and Drive Effective Compliance

Workshop Leaders:

John Hong
Senior Corporate Counsel, Head of U.S. Compliance Monitoring
Pfizer Inc

Ben Brackbill
Sr. Manager, Head of the Compliance Analytics and Reporting Center of Excellence
Pfizer Inc

Josh Raysman
Leader, Pfizer Analytics Lab
Pfizer Inc

Workshop Outline:

I. An Introduction to How Data Can Be Used to Drive Effective Compliance

II. Approaches for Developing a Compliance Dashboard that Tells a Story — Using Real-Life Examples to Show How an Idea Becomes a Fully Developed, Actionable Piece of Work Product

III. An Examination of Other Innovative Techniques, and the Role They May Have in the Continued Evolution of Our Efforts to Identify and Monitor Risk

12:00

Close of Workshop

There will be a 30-minute networking and refreshment break at 10:00 a.m.

M A I N C O N F E R E N C E

12:00

Main Conference Registration

1:15

Chairman’s Welcome and Opening Remarks

Zachary Coseglia
Assistant General Counsel, Head of Global Compliance Monitoring and Analytics
Pfizer Inc

1:30

KEYNOTE PANEL SESSION OIG and DOJ Enforcement Panel — Recent Trends and Areas of Enforcement

MODERATOR:

Joseph Mack
Senior Compliance Counsel, U.S. Office of Compliance,
Bayer U.S.

PANELISTS:

Bernard Cooney
Assistant United States Attorney
District of New Jersey
U.S. Department of Justice

Eric Rubenstein
Special Agent, U.S. Department of Health and Human Services
Office of Inspector General

Kenneth Abell
Chief Civil Health Care Fraud, Eastern District of New York
U.S. Department of Justice

2:30

LIVE POLLING SESSION Best Practices for Leading a Compliance Monitoring Team

Nancy Mark
Director, Monitoring and Compliance
J&J Medical Devices; Health Care Compliance & Privacy
Johnson & Johnson

Amy Pawloski
Global Lead, Compliance Monitoring Strategy
Bristol-Myers Squibb

3:15

Networking and Refreshment Break

3:45

Mitigate Risk in Patient Engagement and Support Programs through
Proactive Monitoring

Erin E. Atkins
Associate
Arent Fox LLP

Amy Wilson
U.S. Compliance Monitoring and Risk Management Lead
Shire

4:30

Adopting Stronger Compliance and Audit Practices to Mitigate Anti-Bribery and Anti-Corruption Risk with Third-Party Vendors

MODERATOR:

Marcus Green
Head of Independent Business Monitoring, Americas
GSK

PANELISTS:

Christine Zettlemoyer, J.D.
Head of Compliance, Americas and Global Support
CSL Behring

Ashley McQuaide
Director, Internal Audit
Olympus Corporation of the Americas

Lauren M. Hickson
Assosciate Director, Compliance Monitoring and Analytics
Allergan

5:15

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWOWEDNESDAY, FEBRUARY 28, 2018

7:30

Continental Breakfast

8:00

Chairperson’s Review of Day One

Zachary Coseglia
Assistant General Counsel, Head of Global Compliance Monitoring and Analytics
Pfizer Inc

8:15

Analyze Three Implementation Journeys of Compliance Monitoring Programs

MODERATOR:

Shawn Reardon
Principal
Independent Commercial Compliance

PANELISTS:

Stuart Levinsky
Health Care Compliance Monitoring, Medical Devices Group
Johnson & Johnson

Eren A. Efe
Senior Manager, Compliance Auditing & Monitoring
Becton Dickinson

Amy Pawloski
Global Lead, Compliance Monitoring Strategy
Bristol-Myers Squibb

Kristin Campisi
Lead, Compliance Monitoring Operations
Bristol-Myers Squibb

9:15

Design Effective and Cost Conscious Field Force Monitoring Practices

Michael Driscoll
Director Oversight and Monitoring/Risk Assessment, Health Care Compliance
Johnson & Johnson

Stacey Aiken
Sr. Manager, Monitoring Analytics
Johnson & Johnson

10:00

Networking and Refreshment Break

10:30

Right-Size your Global Ethics and Compliance Monitoring Program

Zachary Coseglia
Assistant General Counsel, Head of Global Compliance Monitoring and Analytics
Pfizer Inc

11:15

Commercial Observations from a Compliance Monitor

Dan Koerner
Director
Potomac Partners

12:00

Networking Luncheon

1:15

Overcome Resource Constraints — Build a Strategic Approach to Risk Identification, Monitoring and Auditing

Carrie Ann Ashcom
Director, Compliance Monitoring
Zimmer Biomet

2:00

PANEL SESSION Discuss Best Practices for Proactive Monitoring of Ride-Alongs, Speaker Programs and Third-Party Donations and Grants

MODERATOR:

Zachary Coseglia
Assistant General Counsel, Head of Global Compliance Monitoring and Analytics
Pfizer Inc

PANELISTS:

Kelly Pitt
Director, Legal & Compliance
Sobi, Inc.

Shelley L. Hays-Fisher
Senior Manager, Legal and Compliance Department
Jazz Pharmaceuticals Inc.

Amy Wilson
U.S. Compliance Monitoring and Risk Management Lead
Shire

Ann-Marie Tejcek
Senior Director, Ethics and Compliance, Eli Lilly and Company
USA and Canada

3:00

Close of Conference